Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries is currently trading at Rs. 508.00, up by 2.95 points or 0.58% from its previous closing of Rs. 505.05 on the BSE.

The scrip opened at Rs. 501.00 and has touched a high and low of Rs. 509.90 and Rs. 501.00 respectively. So far 52,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 730.75 on 02-Dec-2016 and a 52 week low of Rs. 433.15 on 14-Aug-2017.

Last one week high and low of the scrip stood at Rs. 541.10 and Rs. 501.10 respectively. The current market cap of the company is Rs. 1,21,905.00 crore.

The promoters holding in the company stood at 54.38%, while Institutions and Non-Institutions held 32.05% and 13.57% respectively.

Sun Pharmaceutical Industries has received an approval for the Scheme of Arrangement among Sun Pharma Global FZE (indirect wholly owned subsidiary of the Company) and the company and their respective members and creditors, for demerger of unbranded generic pharmaceutical undertaking of Sun Pharma Global FZE to the Company. The Board of Directors of the Company at their meeting held on November 14, 2017, approved the same on the recommendation of the Audit Committee.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.